Skip to content
zameds

Didanosine

Sold as Videx ec, Aspen didanosine, Nadacine, Sonke-didanosine, Nysivir, Soniren

Every registration of this product has been cancelled.

S4
Loading the molecular structure
C10H12N4O3236.23 g/mol

9-[(2R,5S)-5-(Hydroxymethyl)oxolan-2-yl]-1H-purin-6-one

Drag to rotate. Structure from PubChem CID 135398739.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
4
Registrations
18
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Equity Pharmaceutical (Pty) LtdCancelledVidex ec250 mg360065S4None
Pharmacare limited û woodmeadCancelledAspen didanosine25 mg, 50 mg, 100 mg, 150 mg370442, 370443, 370444, 370445S4None
Aurogen South Africa (Pty) LtdCancelledNadacine, Nysivir, Soniren2 g, 4 g, 100 mg, 150 mg, 200 mg, 250 mg, 400 mg410960, 410961, 410962, 420202, 420203, 440602, 440603, 440604S4None
Ranbaxy (SA) (Pty) LtdCancelledSonke-didanosine25, 50, 100, 250, 400420014, 420015, 420016, 440344, 440345S4None

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Videx ec 250 MG

EACH CAPSULE CONTAINS DIDANOSINE 250,0 mg

250 mg36006536/20.2.8/0065CancelledS4None
Aspen didanosine 25 MG

EACH TABLET CONTAINS DIDANOSINE 25,0 mg

25 mg37044237/20.2.8/0442CancelledS4None
Aspen didanosine 50 MG

EACH TABLET CONTAINS DIDANOSINE 50,0 mg

50 mg37044337/20.2.8/0443CancelledS4None
Aspen didanosine 100 MG

EACH TABLET CONTAINS DIDANOSINE 100,0 mg

100 mg37044437/20.2.8/0444CancelledS4None
Aspen didanosine 150 MG

EACH TABLET CONTAINS DIDANOSINE 150,0 mg

150 mg37044537/20.2.8/0445CancelledS4None
Nadacine tablets 100 MG

EACH TABLET CONTAINS DIDANOSINE 100,0 mg

100 mgTablets41096041/20.2.8/0960CancelledS4None
Nadacine tablets 150 MG

EACH TABLET CONTAINS DIDANOSINE 150,0 mg

150 mgTablets41096141/20.2.8/0961CancelledS4None
Nadacine tablets 200 MG

EACH TABLET CONTAINS DIDANOSINE 200,0 mg

200 mgTablets41096241/20.2.8/0962CancelledS4None
Sonke-didanosine 25

EACH TABLET CONTAINS DIDANOSINE 25,0 mg

2542001442/20.2.8/0014CancelledS4None
Sonke-didanosine 50

EACH TABLET CONTAINS DIDANOSINE 50,0 mg

5042001542/20.2.8/0015CancelledS4None
Sonke-didanosine 100

EACH TABLET CONTAINS DIDANOSINE 100,0 mg

10042001642/20.2.8/0016CancelledS4None
Nysivir oral solution 2 g

EACH 100,0 ml SOLUTION CONTAINS DIDANOSINE 2,0 g

2 gOral solution42020242/20.2.8/0202CancelledS4None
Nysivir oral solution 4 g

EACH 100,0 ml SOLUTION CONTAINS DIDANOSINE 4,0 g

4 gOral solution42020342/20.2.8/0203CancelledS4None
Sonke-didanosine 250

EACH CAPSULE CONTAINS DIDANOSINE 250,0 mg

25044034444/20.2.8/0344CancelledS4None
Sonke-didanosine 400

EACH CAPSULE CONTAINS DIDANOSINE 400,0 mg

40044034544/20.2.8/0345CancelledS4None
Soniren 200 MG capsules

EACH CAPSULE CONTAINS DIDANOSINE 200,0 mg

200 mgCapsules44060244/20.2.8/0602CancelledS4None
Soniren 250 MG capsules

EACH CAPSULE CONTAINS DIDANOSINE 250,0 mg

250 mgCapsules44060344/20.2.8/0603CancelledS4None
Soniren 400 MG capsules

EACH CAPSULE CONTAINS DIDANOSINE 400,0 mg

400 mgCapsules44060444/20.2.8/0604CancelledS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Didanosine

  • S4: Didanosine

    Consolidated Schedules 06 July 2026, line 6026

Pharmacological class: Antiviral agents. (class 20.2.8)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles